Stocks
ANI Pharmaceuticals (ANIP) CAPEX/Revenue US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| CAPEX/Revenue, % | 13.3% | 32.8% | 10.9% | 5.20% | 3.80% | 4.11% | |||
| Changes by years, y/y, % | +8pp | +19pp | -22pp | -6pp | -1pp | -6.8% | |||
ANI Pharmaceuticals. CAPEX/Revenue, %
ANI Pharmaceuticals. CAPEX/Revenue, changes, pp
ANI Pharmaceuticals (ANIP) CAPEX/Revenue US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| CAPEX/Revenue, % | 3.45% | 3.63% | 3.33% | 3.22% | 6.09% | 4.11% | ||
| Changes by years, y/y, % | -8pp | +0pp | +1pp | -3pp | +3pp | |||
| Changes by quarters, q/q, % | -2pp | +0pp | 0pp | 0pp | +3pp | |||
